Search results
Aimin Xu is currently a Chair Professor jointly appointed by the Department of Medicine and the Department of Pharmacology & Pharmacy, and also the director for State Key Laboratory of Pharmaceutical Biotechnology (www.sklpb.hku.hk) at the University of Hong Kong.
Our primary research interest is to investigate the role of adipokines in the pathogenesis of obesity-related insulin resistance, systemic inflammation, T2DM and vascular dysfunctions in animal models and human subjects.
Ye D, Wang Y, Li H, Jia W, Man K, Lo CM, Wang Y, Lam KSL*, Xu A*. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.
Aimin Xu. Department of Medicine, Department of Pharmacology and Pharmacy, the University of Hong Kong. Verified email at hku.hk. Obesity diabetes biomarker discovery adipocyte biology adipokines. Articles Cited by Public access. Title. ... AWK Tso, A Xu, PC Sham, NMS Wat, Y Wang, CHY Fong, BMY Cheung, ... Diabetes care 30 (10), 2667-2672, 2007 ...
ORCID record for aimin xu. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.
Curriculum Vitae-Aimin Xu. A: PERSONAL PROFILE . Telephone Number: (852) 39179754 . Fax number: (852) 28162095; Email address: amxu@hkucc.hku.hk. Contact address: Dept of Medicine, The University of Hong Kong . L8-40, 21 Sassoon Road, Pokfulam, Hong Kong . Personal website: http://www.pharma.hku.hk/pharma/staffweb/DrAiminXu/index.php
You may log into your ResearcherPage with your HKU Portal, and use the "Manage Publications" entry on the green left side menu, to unlink publications from your ResearcherPage, or, select a few to appear in a new box, "Selected Publications".
